Liang et al., 2021 - Google Patents
ApoE4 (Δ272–299) induces mitochondrial‐associated membrane formation and mitochondrial impairment by enhancing GRP75-modulated mitochondrial calcium …Liang et al., 2021
View HTML- Document ID
- 15764597966286858956
- Author
- Liang T
- Hang W
- Chen J
- Wu Y
- Wen B
- Xu K
- Ding B
- Chen J
- Publication year
- Publication venue
- Cell & Bioscience
External Links
Snippet
Abstract Background Apolipoprotein E4 (apoE4) is a major genetic risk factor of Alzheimer's disease. Its C-terminal-truncated apoE4 (Δ272–299) has neurotoxicity by affecting mitochondrial respiratory function. However, the molecular mechanism (s) underlying the …
- 230000002438 mitochondrial 0 title abstract description 85
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liang et al. | ApoE4 (Δ272–299) induces mitochondrial‐associated membrane formation and mitochondrial impairment by enhancing GRP75-modulated mitochondrial calcium overload in neuron | |
| Chen et al. | The heat shock response plays an important role in TDP-43 clearance: evidence for dysfunction in amyotrophic lateral sclerosis | |
| Ho et al. | Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA) | |
| Kim et al. | TREM2 promotes Aβ phagocytosis by upregulating C/EBPα-dependent CD36 expression in microglia | |
| Rodriguez-Rodriguez et al. | Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons | |
| Taylor et al. | Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration | |
| Surguchov | Intracellular dynamics of synucleins:“here, there and everywhere” | |
| Iguchi et al. | Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies | |
| Zaltieri et al. | α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons | |
| Prause et al. | Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis | |
| Bellucci et al. | Redistribution of DAT/α-synuclein complexes visualized by “in situ” proximity ligation assay in transgenic mice modelling early Parkinson's disease | |
| Singaraja et al. | Altered palmitoylation and neuropathological deficits in mice lacking HIP14 | |
| Qing et al. | Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models | |
| Shen et al. | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer’s disease | |
| Liu et al. | WDR91 is a Rab7 effector required for neuronal development | |
| Carulla et al. | Involvement of PrPC in kainate-induced excitotoxicity in several mouse strains | |
| Herzog et al. | TDP-43 misexpression causes defects in dendritic growth | |
| Zou et al. | Autophagy inhibitor LRPPRC suppresses mitophagy through interaction with mitophagy initiator Parkin | |
| Sun et al. | RCAN1 overexpression exacerbates calcium overloading-induced neuronal apoptosis | |
| Couturier et al. | Interaction of double-stranded RNA-dependent protein kinase (PKR) with the death receptor signaling pathway in amyloid β (Aβ)-treated cells and in APPSLPS1 knock-in mice | |
| Naito et al. | Amyloid-β oligomers interact with neurexin and diminish neurexin-mediated excitatory presynaptic organization | |
| Tsai et al. | Impairment in dynein-mediated nuclear translocation by BICD2 C-terminal truncation leads to neuronal migration defect and human brain malformation | |
| Spagnuolo et al. | Haptoglobin increases with age in rat hippocampus and modulates Apolipoprotein E mediated cholesterol trafficking in neuroblastoma cell lines | |
| Zhou et al. | Identification of transthyretin as a novel interacting partner for the δ subunit of GABAA receptors | |
| Gutiérrez et al. | KIF13A drives AMPA receptor synaptic delivery for long-term potentiation via endosomal remodeling |